Ascendia

  MARKET NEWS

Asahi Kasei Develops Novel Membrane System to Dehydrate Organic Solvents Without Heat or Pressure - Contributing to Process Optimization in the Pharmaceutical Industry
Rani Therapeutics Announces Preclinical Pharmacodynamic Data on Transenteric Delivery of GLP-1 Incretin Triagonist
Aptamer Group Signs Material Agreement With Genetic Medicines Company
Clene Announces Publication Describing CNM-Au8 Brain Target Engagement in Neurodegenerative Diseases
Athira Pharma Announces Encouraging Results From SHAPE Phase 2 Clinical Trial of Fosgonimeton for the Treatment of Parkinson's Disease Dementia & Dementia With Lewy Bodies
ADMA Biologics Announces FDA Approval for BIVIGAM in the Pediatric Patient Setting for Those 2 Years of Age & Older

  FEATURED EDITORIAL

  COMPANY PROFILE

As a specialty CDMO, Aprecia is redefining medicine so patients can live their best lives. Our life transforming innovations in 3D Printing (3DP) expand the possibilities for patient centricity in pharmaceutical product development. Agile production systems enable liberating formulation platforms that set a new standard in modern pharmaceutics, creating better products in better ways in less time. Aprecia is the only company in the world to scale-up manufacturing for a 3DP product, win regulatory approval, and reliably produce commercial supply. Our proven 3DP technology is taking existing medicines to their full potential and accelerating development for a new spectrum of early-stage product candidates. Click here for more.

  EXCLUSIVE ONLINE CONTENT

Global Confidence in Drug Delivery Innovation Remains at Record Highs According to Pharmapack

Global Confidence in Drug Delivery Innovation Remains at Record Highs According to Pharmapack

The annual Pharmapack Drug Delivery Innovation Index is released ahead of Europe’s premier drug delivery and packaging event, Pharmapack Europe 2024 (January 24-25) – held at the Paris Expo, Porte de Versailles (Hall 7.2). The results showed….

Roche Completes Acquisition of Telavant From Roivant, Including Rights to Novel TL1A Directed Antibody for Inflammatory Bowel Disease Treatment

Roche Completes Acquisition of Telavant From Roivant, Including Rights to Novel TL1A Directed Antibody for Inflammatory Bowel Disease Treatment

Roivant recently announced the completion of the previously announced acquisition by Roche of Telavant, for an upfront payment of approximately $7.1 billion…..

Aeterna Zentaris & Ceapro Announce Merger to Create Diversified Biopharmaceutical Company

Aeterna Zentaris & Ceapro Announce Merger to Create Diversified Biopharmaceutical Company

Aeterna Zentaris Inc. and Ceapro Inc. recently announced they have entered into a definitive agreement to combine operations in an all-stock merger of equals transaction…..

ReciBioPharm Partners With Acuitas Therapeutics to Provide Rapid Technology Transfers & cGMP Manufacture of LNP Formulations

ReciBioPharm Partners With Acuitas Therapeutics to Provide Rapid Technology Transfers & cGMP Manufacture of LNP Formulations

ReciBioPharm, the advanced and emerging therapies business unit within Recipharm, and biotechnology firm Acuitas Therapeutics have recently announced they are taking their partnership to the next level….

  WHITEPAPERS & WEBINARS

WEBINAR - 2024 Trends in Topical Drug Delivery: Insights & Innovation

WEBINAR - 2024 Trends in Topical Drug Delivery: Insights & Innovation

This webinar will discuss some of the key trends from these leaders in the topical market on both a global and regional level, including the increased importance of sensory properties and the rise in non-conventional product formats, among others…..

WEBINAR - Enabling Upstream Intensified Bioprocessing

WEBINAR - Enabling Upstream Intensified Bioprocessing

Intensified upstream bioprocesses are being developed to increase productivity while reducing footprint, costs, and timelines for manufacturing. The higher cell densities generated by….

  WHITEPAPERS & WEBINARS

WHITEPAPER - Minimizing API Supply Chain Risks

WHITEPAPER - Minimizing API Supply Chain Risks

By the time your API is brought to a contract manufacturing organization (CMO), you have already put extensive amounts of resources into developing it. It becomes essential that you optimize your API supply chain to be aware of potential risks

…

WHITEPAPER: Innovating Pharma Barrier Packaging for a Sustainable Future

WHITEPAPER: Innovating Pharma Barrier Packaging for a Sustainable Future

Honeywell Aclar® thermoformable film enables pharmaceutical and medical device companies to achieve their sustainability commitments.

Aclar® film not only delivers a high moisture barrier to protect medicines, but it also reduces pack size, reduces waste, and reduces carbon emissions, compared

…

WHITEPAPER - Copolymer Microstructures: Connecting Monomer Sequence Distribution With Biomedical End-Application Performance

WHITEPAPER - Copolymer Microstructures: Connecting Monomer Sequence Distribution With Biomedical End-Application Performance

By: Dr. Bahar Yeniad and Dr. Pieter van Delft

Experts in copolymer microstructures have an important role to play in selecting biomaterials that can deliver desired performance of (bio)medical products. But how does microstructure link to the rate of API …

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

January 3 – Capsules
January 10 – Excipients